Evidence map›Paper›PMID 42883511›Full record

ArticleFoods (Basel, Switzerland)2026

Screening and Evaluation of

Yueting Ge, Kaile Chen, Zhenguo Tian, Chengjia Gu, Boyang Kou, Guowei Le, Yuhui Yang

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yueting GeHenan Key Laboratory of Tea Plant Biology, College of Tea and Food Science, Xinyang Normal University, Xinyang 464000, China.
Kaile ChenCollege of Food Science and Engineering, Henan University of Technology, 100 Lotus Street, Hi-Tech Development District, Zhengzhou 450001, China.
Zhenguo TianCollege of Food Science and Engineering, Henan University of Technology, 100 Lotus Street, Hi-Tech Development District, Zhengzhou 450001, China.
Chengjia GuHenan Key Laboratory of Tea Plant Biology, College of Tea and Food Science, Xinyang Normal University, Xinyang 464000, China.
Boyang KouHenan Key Laboratory of Tea Plant Biology, College of Tea and Food Science, Xinyang Normal University, Xinyang 464000, China.
Guowei LeState Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Yuhui YangCollege of Food Science and Engineering, Henan University of Technology, 100 Lotus Street, Hi-Tech Development District, Zhengzhou 450001, China.ORCID 0000-0002-4949-3745

Funding

Henan Science and Technology Department 262102110145Henan University of Technology 2024TXTD08Henan University of Technology GO202609National Natural Science Foundation of China 32302077Xinyang Normal University
6 · The paper itself

Abstract

Advanced glycation end products (AGEs), stable glycation/glycoxidation products generated during thermal processing, accumulate in foods and pose health risks. Current mitigation strategies primarily focus on inhibiting AGEs formation rather than reducing already formed products, highlighting the need for effective approaches to reduce pre-formed AGEs. In this study, a food-grade lactic acid bacterium (LAB) capable of efficiently reducing fluorescent AGEs was isolated from naturally fermented foods using AGEs as the primary nitrogen source. From 1213 presumptive LAB isolates, three candidates with fluorescent AGEs reduction rates exceeding 50% were obtained, among which strain HNGD-YC1 exhibited the highest activity and was selected for further characterization. The strain was identified as

Indexed as

advanced glycation end productsidentificationlactic acid bacteriaLactiplantibacillus plantarumscreening

Identifiers

PMID42883511
PMCPMC13664014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.